Differential down-regulation of CD28 by B7-1 and B7-2 engagement

Transplantation. 1997 Nov 27;64(10):1497-9. doi: 10.1097/00007890-199711270-00025.

Abstract

Physiologically relevant full activation of T cells requires signal transduction through the T cell receptor and additional costimulatory cell surface molecules. Best understood of these costimulatory interactions are those between CD28 and its ligands B7-1 (CD80) and B7-2 (CD86). While B7-1 and B7-2 bind the same receptors (CD28 and CTLA-4), they share only 25% sequence homology, are expressed at different times during immune responses, and in some systems have been shown to differentially affect T cell cytokine expression. Although CD28 is an activation antigen, its expression is down-regulated after engagement by B7-1. Here we show that B7-2 engagement is considerably less effective at down-regulating CD28, which indicates a differential effect of these two CD28 ligands on activated T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, CD / pharmacology*
  • B7-1 Antigen / pharmacology*
  • B7-2 Antigen
  • CD28 Antigens / physiology*
  • CHO Cells / metabolism
  • Cricetinae
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • Membrane Glycoproteins / pharmacology*
  • Mice
  • Mice, Inbred BALB C

Substances

  • Antigens, CD
  • B7-1 Antigen
  • B7-2 Antigen
  • CD28 Antigens
  • Cd86 protein, mouse
  • Membrane Glycoproteins